These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9609842)

  • 1. [Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
    Serrano J; Verdú J; Martínez A; Antón A; Caballero O
    Rev Esp Med Nucl; 1998; 17(1):35-9. PubMed ID: 9609842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
    Meng Z; Tan J; Zhang M; Dong F; Jia Q; Zhang F
    Clin Nucl Med; 2009 Jul; 34(7):479-82. PubMed ID: 19542965
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone scintigraphy in hungry bone syndrome following parathyroidectomy.
    Hardoff R; Frajewicki V
    J Nucl Med; 1996 Aug; 37(8):1371-3. PubMed ID: 8708777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary hyperparathyroidism due to parathyroid carcinoma].
    Megino Moreno T; Herranz Antolín S; Bernal Bello D; Alvarez De Frutos V
    Endocrinol Nutr; 2010 Dec; 57(10):504-6. PubMed ID: 20951655
    [No Abstract]   [Full Text] [Related]  

  • 5. Parathyroid and bone scintigraphy in hyperparathyroidism.
    Shi H; Chen J; Chen S
    Clin Nucl Med; 2005 Nov; 30(11):769-70. PubMed ID: 16237313
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent nonfunctioning parathyroid carcinoma and parathyroid adenoma.
    Ashkenazi D; Elmalah I; Rakover Y; Luboshitzky R
    Am J Otolaryngol; 2006; 27(3):204-6. PubMed ID: 16647986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of metastatic parathyroid carcinoma with Tc-99m sestamibi imaging.
    Al-Sobhi S; Ashari LH; Ingemansson S
    Clin Nucl Med; 1999 Jan; 24(1):21-3. PubMed ID: 9890488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease.
    Pai M; Park CH; Kim BS; Chung YS; Park HB
    Clin Nucl Med; 1997 Oct; 22(10):691-4. PubMed ID: 9343725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
    Neumann DR; Esselstyn CB; Kim EY
    J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent papillary thyroid cancer and parathyroid adenoma as a rare condition: a case report.
    Javadi H; Jallalat S; Farrokhi S; Semnani S; Mogharrabi M; Riazi A; Nabipour I; Moshtaghi D; Assadi M
    Nucl Med Rev Cent East Eur; 2012 Aug; 15(2):153-5. PubMed ID: 22936512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfunctioning intrathyroidal parathyroid carcinoma.
    Hussein WI; El-Maghraby TA; Al-Sanea O
    Saudi Med J; 2006 Aug; 27(8):1226-9. PubMed ID: 16883457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid carcinoma with metastatic calcification identified by technetium-99m methylene diphosphonate scintigraphy.
    Aso Y; Sato A; Tayama K; Takanashi K; Satoh H; Takemura Y
    Intern Med; 1996 May; 35(5):392-5. PubMed ID: 8797054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible extraskeletal uptake of bone scanning in primary hyperparathyroidism.
    Hwang GJ; Lee JD; Park CY; Lim SK
    J Nucl Med; 1996 Mar; 37(3):469-71. PubMed ID: 8772648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bone scan, no mistake!
    Decock A; De Geeter F; De Vriese A; Depaepe P; Van den Bruel A
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4447-8. PubMed ID: 25250637
    [No Abstract]   [Full Text] [Related]  

  • 16. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT; Rimkus DR; Hartzman S; Latimer RG
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid adenoma localization with 99mTc-MDP bone scintigraphy.
    Bohmer DR; Mercer MP; Turner GJ
    Aust N Z J Surg; 2000 Nov; 70(11):817-9. PubMed ID: 11147446
    [No Abstract]   [Full Text] [Related]  

  • 18. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
    Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic mediastinal parathyroid carcinoma as a cause of dialysis-dependent renal failure.
    Tkaczyk M; Czupryniak A; Nowicki M
    Hemodial Int; 2007 Oct; 11(4):398-402. PubMed ID: 17922734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of technetium Tc 99m sestamibi for detection of a parathyroid adenoma in a dog with primary hyperparathyroidism.
    Matwichuk CL; Taylor SM; Wilkinson AA; Dudzic EM; Matte GG; Outerbridge CA; Schmon CL; Ihle SL
    J Am Vet Med Assoc; 1996 Nov; 209(10):1733-6. PubMed ID: 8921031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.